A股異動 | 文燦股份一度升超8% 獲客户兩大項目定點 總銷售額預計最多41億元
格隆匯7月24日丨文燦股份(603348.SH)盤中一度升超8%,最高報52.84元逼近階段高價,暫成交3.94億元,總市值137億元。該股週五盤後披露獲得客户項目定點的公吿,涉及大型一體化車身結構件和汽車電池盒兩大項目,生命週期總銷售金額預計合計37億元-41億元。根據鋰電池製造商客户的規劃,此次定點的電池盒項目共計2個,生命週期十二年,生命週期總銷售金額預計約為14億元-15億元。該定點項目預計2024年第四季度逐步開始量產。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.